Keywords: حامل مونوآمین Vesicular; AZ; active zone; BoNT; botulinum neurotoxin; CAZ; cytomatrix at the active zone; GFAP; glial fibrillary acidic protein; Munc; mammalian uncoordinated; Nrxn1; Neurexin 1-alpha; RABV; rabies virus; RIM; regulating synaptic membrane exocytosis protein; RIM-B
مقالات ISI حامل مونوآمین Vesicular (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: حامل مونوآمین Vesicular; Aβ; beta-amyloid; APOE; apolipoprotein E; APP; amyloid precursor protein; AD; Alzheimer's disease; CRISPR; clustered regularly interspaced short palindromic repeats; DAT; dopamine transporter; ER; estrogen receptor; FAD; familial Alzheimer's disease;
Keywords: حامل مونوآمین Vesicular; Dopamine; Ecstasy; Methamphetamine; METH; 3,4-Methylenedioxymethamphetamine; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat; AC; adenylyl cyclase; AcbSh; nucleus accumbens shell; AcbC; nucleus accumbens core; cAMP;
Keywords: حامل مونوآمین Vesicular; ADHD; attention hyperactive disorder; AKT; protein kinase B; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Bcl-2; B-cell lymphoma 2; BDNF; brain derived neurotrophic factor; Css; Steady state plasma concentration; D1; type 1 dopamine recept
Keywords: حامل مونوآمین Vesicular; DOPAC; 3,4-dihydroxyphenylacetic acid; 5-HIAA; 5-hydroxyindoleacetic acid; HPLC; high precision liquid chromatography; PCA; principal component analysis; ANOVA; analysis of variance; HSD; Honestly Significant Difference; D1-R; D1 receptor; SF; short fin;
Keywords: حامل مونوآمین Vesicular; AA; arachidonic acid; AD; adrenaline; CA; catecholamines; COMT; catechol-O-methyltransferase; CDV; cardiovascular; DHA; docosahexaenoic acid; EA; elaidic acid; EP3R; prostaglandin E3 receptor; EPA; eicosapentaenoic acid; FA; fatty acid; GAPDH; glyceraldeh
Keywords: حامل مونوآمین Vesicular; DA; dopamine; PD; Parkinson's disease; ADHD; attention-deficit hyperactivity disorder; ASD; autism spectrum disorders; SRY; sex-determining region on the Y chromosome; SNc; substantia nigra pars compacta; SNr; substantia nigra pars reticulata; VTA; ventra
Keywords: حامل مونوآمین Vesicular; 5-HT; 5-hydroxytryptamine, serotonin; CRF; corticotropin-releasing factor; HPA; hypothalamus-pituitary-adrenal; WHO; World Health Organization; DSM-5; Diagnostic and Statistical Manual of Mental Disorders 5; MOA; monoamine oxidase; VMAT; vesicular monoami
Keywords: حامل مونوآمین Vesicular; [123I]-β-CIT; 123I-labelled 2b-carbomethoxy-3b-(4-iodophenyl) tropane; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; 5-hydroxytryptamine, serotonin; 5-HTT; serotonin transporter; ADHD; attention deficit hyperactivity disorder; AMPH; amphetamine; ATS; ampheta
Keywords: حامل مونوآمین Vesicular; Catecholamine; Dopamine; Norepinephrine; Parkinson's disease; Neurodegeneration; AAG; autoimmune autonomic ganglionopathy; ALDH; aldehyde dehydrogenase; AMYL; amyloidosis; CAF; chronic autonomic failure; DA; dopamine; DHPG; 3,4-dihydroxyphenylglycol; DOPA
Keywords: حامل مونوآمین Vesicular; GLU; Glucagon; INS; Insulin; IR; Immunoreactivity; PET; Positron emission tomography; PP; Pancreatic polypeptide; SOM; Somatostatin; T1DM; Type 1 diabetes model; VMAT2; Vesicular monoamine transporter;
Keywords: حامل مونوآمین Vesicular; Antioxidant gene therapy; Brain ischemia; Neurodegenerative disorders; Oxidative stress; Virus-mediated gene delivery; ROS; ÎΨm; mitochondrial membrane potential; 3-NP; 3-nitropropionic acid; 6-OHDA; 6-hydroxydopamine; AADC; aromatic-l-amino decarboxyla
Keywords: حامل مونوآمین Vesicular; CNS; central nervous system; DAT; dopamine transporter; GABA; gamma-aminobutyric acid; GAT; gamma-aminobutyric acid (GABA) transporter; GLT; glutamate transporter; iDAT; invertebrate dopamine transporter; NAT; noradrenaline transporter; NTT; neurotransmit
GZ-793A inhibits the neurochemical effects of methamphetamine via a selective interaction with the vesicular monoamine transporter-2
Keywords: حامل مونوآمین Vesicular; Methamphetamine; Vesicular monoamine transporter; Dopamine; Lobeline; Lobelane; Drug discovery;
Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss
Keywords: حامل مونوآمین Vesicular; MPTP; Stereology; Tyrosine hydroxylase; Dopamine transporter; Vesicular monoamine transporter; Dopamine;
The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders
Keywords: حامل مونوآمین Vesicular; AADC; aromatic l-amino acid decarboxylase; AR/ADGTPCH; autosomal recessive/dominant GTP-cyclohydrolase deficiency; BH4; tetrahydrobiopterin; DAT; dopamine transporter; DÃH; dopamine β-hydroxylase; DHFR; dihydrofolate reductase deficiency; DHPR; dihydrop
Vesicular monoamine transporter 2 (Vmat2) knockdown elicits anxiety-like behavior in zebrafish
Keywords: حامل مونوآمین Vesicular; Vesicular monoamine transporter 2; Anxiety; Zebrafish; VMAT; vesicular monoamine transporter; WT; wild-type; DA; dopamine; 5-HT; 5-hydroxytryptamine; NE; norepinephrine;
The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter
Keywords: حامل مونوآمین Vesicular; Amphetamines; Dopamine transporter; Noradrenaline transporter; Serotonin transporter; Vesicular monoamine transporter; Synaptic vesicles;
Drosophila melanogaster as a genetic model system to study neurotransmitter transporters
Keywords: حامل مونوآمین Vesicular; 5HT; 5-hydroxytryptamine (serotonin); ACh; acetylcholine; ASD; autism spectrum disorder; ChT; choline transporter; ChAT; choline acetyl transferase; DA; dopamine; Ddc; dopa decarboxylase; EAAT; excitatory amino acid transporter; GABA; gamma amino butyric
PET quantification of pancreatic VMAT 2 binding using (+) and (â) enantiomers of [18Â F]FP-DTBZ in baboons
Keywords: حامل مونوآمین Vesicular; Vesicular monoamine transporter; β-cell mass; PET; [18 F]FP-DTBZ;
Vesicular Ca2+ mediates granule motion and exocytosis
Keywords: حامل مونوآمین Vesicular; V-ATPase; vesicular H+-ATPase; VMAT2; vesicular monoamine transporter; LDCV; large dense core vesicles; Cgs; chromogranins; CgA; chromogranin A; CgB; chromogranin B; SgII; secretogranin type II; SERCA; sarcoplasmic reticulum calcium ATPase; CICR; Ca2+-ind
Alteration of serotonin system by polychlorinated biphenyls exposure
Keywords: حامل مونوآمین Vesicular; 5-HIAA; 5-hydroxy-indole acetic acid; 5-HT; 5-hydroxytriptophan (serotonin); AAAD; aromatic l-aminoacid decarboxylase; ACTH; adrenocorticotropic hormone; AhR; aryl hydrocarbon receptor; ARNT; AhR nuclear translocator; BSID; Bayley scales of infant develop
Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands
Keywords: حامل مونوآمین Vesicular; Dihydrotetrabenazine; Vesicular monoamine transporter; Parkinson’s disease; Positron emission tomography
Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells
Keywords: حامل مونوآمین Vesicular; Actin; Dopamine; Jurkat; Proteomics; T-cells; 2-DE; two-dimensional electrophoresis; CHAPS; 3-[(3-cholamido)dimethylammonio]-1-propanesulfonic acid; CNS; central nervous system; DAT; dopamine transporter; DTT; dithiothreitol; FBS; fetal bovine serum; GO;
A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons
Keywords: حامل مونوآمین Vesicular; Parkinson's disease; Tyrosine hydroxylase; Vesicular monoamine transporter; Gene therapy; Cell death; Neurodegeneration
l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?
Keywords: حامل مونوآمین Vesicular; AADC; aromatic l-amino acid decarboxylase; ALDH; aldehyde dehydrogenase; AMPA; α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate; AR; aldehyde reeductase; ATP; adenosine triphosphate; Bax; Bcl-2-associated X protein; BDNF; brain-derived neurotrophic fac
In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations
Keywords: حامل مونوآمین Vesicular; Tetrabenazine; Dopamine; Tomography, emission computed; Vesicular monoamine transporter; α-Methyl-p-tyrosine
Neuroendocrine markers are expressed in human mammary glands
Keywords: حامل مونوآمین Vesicular; Breast; Chromogranin; Ghrelin; Obestatin; Secretogranin; Vesicular monoamine transporter
Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen
Keywords: حامل مونوآمین Vesicular; Dopamine transporter; Vesicular monoamine transporter; Dopamine receptors; Lymphoid organ; Western blot analysis; Immunohistochemistry
Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2
Keywords: حامل مونوآمین Vesicular; Vesicular monoamine transporter; Lobelane; Structure–activity relationship
Lobeline effects on tonic and methamphetamine-induced dopamine release
Keywords: حامل مونوآمین Vesicular; Methamphetamine; Lobeline; Dopamine; Vesicular monoamine transporter; Dopamine transporter
Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2
Keywords: حامل مونوآمین Vesicular; Vesicular monoamine transporter; VMAT; Amphetamine; Methylphenidate; Synaptic vesicle; ADHD
Pharmacokinetics of [18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain
Keywords: حامل مونوآمین Vesicular; Vesicular monoamine transporter; Tomography, emission computed; Tetrabenazine
Comparative immunohistochemical study of the dopaminergic systems in two inbred mouse strains (C57BL/6J and DBA/2J)
Keywords: حامل مونوآمین Vesicular; Prefrontal cortex; Dopamine transporter; Vesicular monoamine transporter; Mesocortical pathways; Mesolimbic pathways; Galanin; Neurotensin
Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP
Keywords: حامل مونوآمین Vesicular; Parkinson's disease; Striatum; Dopamine transporter; Vesicular monoamine transporter; Tyrosine hydroxylase; α-Synuclein;
Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters
Keywords: حامل مونوآمین Vesicular; Lobeline; Dopamine transporter; Serotonin transporter; Vesicular monoamine transporter
Altered ethanol-associated behaviors in vesicular monoamine transporter heterozygote knockout mice
Keywords: حامل مونوآمین Vesicular; Monoamines; Alcoholism; Vesicular monoamine transporter; Knockout mice; Reward;
Platelet vesicular monoamine transporter density in untreated patients diagnosed with social phobia
Keywords: حامل مونوآمین Vesicular; Social phobia; Vesicular monoamine transporter; Platelet; [3H]dihydrotetrabenazine;
Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patients
Keywords: حامل مونوآمین Vesicular; Schizophrenia; Vesicular monoamine transporter; Platelet; Smoking;
Psychostimulants and monoamine transporters: upsetting the balance
Keywords: حامل مونوآمین Vesicular; ADHD; attention deficit hyperactivity disorder; AMPH; amphetamine; CPP; conditioned place preference; DAT; dopamine transporter; KO; knockout; METH; methamphetamine; MDMA; 3,4-methylenedioxymethamphetamine; NET; norepinephrine transporter; PKC; protein ki
Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease
Keywords: حامل مونوآمین Vesicular; Dopamine; Tetrahydrobiopterin; Ketanserin; Oxidative stress; Parkinson's disease; Vesicular monoamine transporter;
Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia
Keywords: حامل مونوآمین Vesicular; AA; arachidonic acid; Acb; nucleus accumbens; ACC; anterior cingulate cortex; ADP; adenosine diphosphate; Amg; amygdala; BPRS; brief psychiatric rating score; CA1-3; CA1-3 fields of the hippocampus; CHO; carbohydrate; CPRS; comprehensive psychiatric r
Lobelane analogues as novel ligands for the vesicular monoamine transporter-2
Keywords: حامل مونوآمین Vesicular; Lobeline; Methamphetamine; Vesicular monoamine transporter; Structure–activity relationships
Mechanisms of neurotransmitter release by amphetamines: A review
Keywords: حامل مونوآمین Vesicular; AMPH; amphetamine; CHO; Chinese hamster ovary; DAT; dopamine (plasma membrane) transporter; GABA; gamma-aminobutyric acid; hDAT; human DAT; MAO; monoamine oxidase; MDMA; 3,4-methylenedioxymethamphetamine; METH; methamphetamine; NET; norepinephrine transpo